InvestorsHub Logo
icon url

TheDane

05/13/21 8:38 AM

#359116 RE: DaubersUP #359102

I think it’s going according to plan. Leo said...”Patient enrollment in the Phase 2 study of Brilacidin for COVID-19 is moving along quickly, far faster in recruitment than other COVID-19 studies we’ve seen in industry reports.”

Even if recruitment is done by the end of may there’s another month to go. Unfortunately!